News for Masimo Corporation (MASI)

“As the old phrase goes, don’t catch a falling knife.”

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Masimo (MASI) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Masimo (MASI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Masimo (MASI) could produce exceptional returns because of its solid growth attributes.

Masimo, Robinhood Markets and Discover Financial Services are part of the Zacks Screen of the Week article.

**media[561884]**

SAN DIEGO, March 04, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP, a shareholder rights law firm, is investigating potential violations of federal and state l

Masimo (MASI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Masimo (MASI) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Masimo (MASI) possesses solid growth attributes, which could help it handily outperform the market.

[url="]Masimo[/url] (NASDAQ: MASI) today announced that its management will participate in the 46th Annual Raymond James Institutional Investor Conference on T

Masimo (MASI) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Masimo Corporation (NASDAQ:MASI) Q4 2024 Earnings Conference Call February 25, 2025 4:30 PM ETCompany ParticipantsEli Kammerman - Vice President, Business...

The following slide deck was published by Masimo Corporation in conjunction with their 2024 Q4 earnings call.

Masimo (Nasdaq: MASI) today announced its financial results for the fourth quarter and full-year ended December 28, 2024 and provided updated estimates for its

Fresenius Medical, Masimo, Merit Medical Systems and Inogen are included in this Analyst Blog.